These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

734 related articles for article (PubMed ID: 11135435)

  • 1. A search for germline APC mutations in early onset colorectal cancer or familial colorectal cancer with normal DNA mismatch repair.
    Boardman LA; Schmidt S; Lindor NM; Burgart LJ; Cunningham JM; Price-Troska T; Snow K; Ahlquist DA; Thibodeau SN
    Genes Chromosomes Cancer; 2001 Feb; 30(2):181-6. PubMed ID: 11135435
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of somatic molecular changes, clinicopathological features, family history, and germline mutations in colorectal cancer families: evidence for efficient diagnosis of HNPCC and for the existence of distinct groups of non-HNPCC families.
    Johnson V; Lipton LR; Cummings C; Eftekhar Sadat AT; Izatt L; Hodgson SV; Talbot IC; Thomas HJ; Silver AJ; Tomlinson IP
    J Med Genet; 2005 Oct; 42(10):756-62. PubMed ID: 15788729
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic analysis of the APC gene regions involved in attenuated APC phenotype in Israeli patients with early onset and familial colorectal cancer.
    Figer A; Irmin L; Geva R; Flex D; Sulkes A; Friedman E
    Br J Cancer; 2001 Aug; 85(4):523-6. PubMed ID: 11506490
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Eight novel MSH6 germline mutations in patients with familial and nonfamilial colorectal cancer selected by loss of protein expression in tumor tissue.
    Plaschke J; Krüger S; Dietmaier W; Gebert J; Sutter C; Mangold E; Pagenstecher C; Holinski-Feder E; Schulmann K; Möslein G; Rüschoff J; Engel C; Evans G; Schackert HK;
    Hum Mutat; 2004 Mar; 23(3):285. PubMed ID: 14974087
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel germline mutation (300-305delAGTTGA) in the human MSH2 gene in hereditary non-polyposis colorectal cancer (HNPCC).
    Glasl S; Papatheodorou L; Baretton G; Jung C; Gross M
    Hum Mutat; 2000 Jul; 16(1):91-2. PubMed ID: 10874318
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nontruncating APC germ-line mutations and mismatch repair deficiency play a minor role in APC mutation-negative polyposis.
    Heinimann K; Thompson A; Locher A; Furlanetto T; Bader E; Wolf A; Meier R; Walter K; Bauerfeind P; Marra G; Müller H; Foernzler D; Dobbie Z
    Cancer Res; 2001 Oct; 61(20):7616-22. PubMed ID: 11606402
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular genetic alterations and clinical features in early-onset colorectal carcinomas and their role for the recognition of hereditary cancer syndromes.
    Losi L; Di Gregorio C; Pedroni M; Ponti G; Roncucci L; Scarselli A; Genuardi M; Baglioni S; Marino M; Rossi G; Benatti P; Maffei S; Menigatti M; Roncari B; Ponz de Leon M
    Am J Gastroenterol; 2005 Oct; 100(10):2280-7. PubMed ID: 16181381
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutational analysis of the transforming growth factor beta receptor type II gene in hereditary nonpolyposis colorectal cancer and early-onset colorectal cancer patients.
    Shin KH; Park YJ; Park JG
    Clin Cancer Res; 2000 Feb; 6(2):536-40. PubMed ID: 10690536
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Familial colorectal cancer in Ashkenazim due to a hypermutable tract in APC.
    Laken SJ; Petersen GM; Gruber SB; Oddoux C; Ostrer H; Giardiello FM; Hamilton SR; Hampel H; Markowitz A; Klimstra D; Jhanwar S; Winawer S; Offit K; Luce MC; Kinzler KW; Vogelstein B
    Nat Genet; 1997 Sep; 17(1):79-83. PubMed ID: 9288102
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [From gene to disease; from DNA 'mismatch' repair genes to hereditary non-polyposis colorectal carcinoma].
    Wijnen JT; Morreau H; Vasen HF
    Ned Tijdschr Geneeskd; 2001 Apr; 145(16):780-2. PubMed ID: 11346916
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Recent notions on intestinal cancerogenesis, their implications in genetic risk screening and preventive action of non-steroid anti-inflammatory agents].
    Couturier D
    Bull Acad Natl Med; 2002; 186(2):421-43; discussion 443-5. PubMed ID: 12145848
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel missense germline mutation in exon 2 of the hMSH2 gene in a HNPCC family from Southern Italy.
    Baudi F; Fersini G; Lavecchia A; Terracciano R; Leone F; Quaresima B; Faniello MC; De Paola L; Doldo P; Cuda G; Costanzo F; Venuta S
    Cancer Lett; 2005 Jun; 223(2):285-91. PubMed ID: 15896463
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of occult high graded microsatellite instabilities in MMR gene mutation negative HNPCC tumors by addition of complementary marker analysis.
    Schiemann U; Müller-Koch Y; Gross M; Glas J; Baretton G; Muders M; Mussack T; Holinski-Feder E
    Eur J Med Res; 2005 Jan; 10(1):23-8. PubMed ID: 15737950
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Familial adenomatous polyposis (FAP) and hereditary nonpolyposis colorectal cancer (HNPCC): a review of clinical, genetic and therapeutic aspects.
    Soravia C; Bapat B; Cohen Z
    Schweiz Med Wochenschr; 1997 Apr; 127(16):682-90. PubMed ID: 9140167
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HMSH6 alterations in patients with microsatellite instability-low colorectal cancer.
    Parc YR; Halling KC; Wang L; Christensen ER; Cunningham JM; French AJ; Burgart LJ; Price-Troska TL; Roche PC; Thibodeau SN
    Cancer Res; 2000 Apr; 60(8):2225-31. PubMed ID: 10786688
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Environmental factors and colorectal tumor risk in individuals with hereditary nonpolyposis colorectal cancer.
    Diergaarde B; Braam H; Vasen HF; Nagengast FM; van Muijen GN; Kok FJ; Kampman E
    Clin Gastroenterol Hepatol; 2007 Jun; 5(6):736-42. PubMed ID: 17544999
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular analysis of colorectal cancer tumors from patients with mismatch repair proficient hereditary nonpolyposis colorectal cancer suggests novel carcinogenic pathways.
    Sánchez-de-Abajo A; de la Hoya M; van Puijenbroek M; Tosar A; López-Asenjo JA; Díaz-Rubio E; Morreau H; Caldes T
    Clin Cancer Res; 2007 Oct; 13(19):5729-35. PubMed ID: 17908962
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BAT-26 identifies sporadic colorectal cancers with mutator phenotype: a correlative study with clinico-pathological features and mutations in mismatch repair genes.
    Cravo M; Lage P; Albuquerque C; Chaves P; Claro I; Gomes T; Gaspar C; Fidalgo P; Soares J; Nobre-Leitão C
    J Pathol; 1999 Jul; 188(3):252-7. PubMed ID: 10419591
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic testing for germline mutations of the APC gene in patients with apparently sporadic desmoid tumors but a family history of colorectal carcinoma.
    Brueckl WM; Ballhausen WG; Förtsch T; Günther K; Fiedler W; Gentner B; Croner R; Boxberger F; Kirchner T; Hahn EG; Hohenberger W; Wein A
    Dis Colon Rectum; 2005 Jun; 48(6):1275-81. PubMed ID: 15793634
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Germline mutations of the APC gene in two Japanese adenomatous polyposis patients.
    Nimura Y; Furuwatari C; Fujimori M; Fujimori Y; Nakata S; Ito K; Hama Y; Shingu K; Adachi W; Ogiso Y; Furihata K; Katsuyama T; Amano J
    Jpn J Hum Genet; 1997 Sep; 42(3):433-9. PubMed ID: 12503191
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.